Univar Inc. (UNVR - Free Report) is a global distributor of chemicals and innovative services. Let’s have a quick look at the chemical company’s second-quarter 2018 release.
Univar’s adjusted earnings for the second quarter were 47 cents, missing the Zacks Consensus Estimate of 48 cents.
Univar recorded net sales of $2,372.6 million, up 5.6% year over year. It surpassed the Zacks Consensus Estimate of $2,343.1 million.
Univar Inc. Price and EPS Surprise
Estimate Trend & Surprise History
Investors should note that the earnings estimate for Univar for the second quarter has been stable over the past month. Univar has beaten the Zacks Consensus Estimate in all of the trailing four quarters with an average beat of 26.9%.
Key Stats/Developments to Note
For full-year 2018, Univar reaffirmed adjusted EBITDA growth of low-double digits. For 2018, the company continues to expect adjusted earnings in the range of $1.65-$1.85 per share.
The company also expects low double digit growth in adjusted EBITDA for the third quarter.
Currently, Univar has a Zacks Rank #3 (Hold) but that could change following its earnings report which has just released. Meanwhile, you can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Univar’s shares were inactive in premarket trading. It would be interesting to see how the market reacts to the results during the trading session today.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana. Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>